20mg/ml GS-441524 Injection 8ml Vial for Subcutaneous FIP Treatment in Cats
Product Overview
GS-441524 is a nucleoside analog compound used in veterinary antiviral programs associated with feline infectious peritonitis (FIP). In clinical discussions related to feline health management, this compound is frequently mentioned as part of structured treatment approaches designed for cats diagnosed with FIP.
The product is provided as a 20mg/ml injectable formulation in an 8ml sterile vial. This configuration allows flexible dosage planning based on the body weight of the animal. Injectable administration is commonly selected because it provides stable absorption during long-term treatment protocols.
Manufactured in China, each vial is sealed and labeled to ensure product identification, storage safety, and traceability during distribution.
Product Specifications
| Product Name | GS-441524 Injection |
| CAS Number | 1191237-69-0 |
| Concentration | 20mg/ml |
| Dosage Form | Injectable Solution |
| Vial Size | 8ml per vial |
| Storage Condition | Room Temperature |
| Shelf Life | 1 Year from Date of Manufacture |
| Country of Manufacture | China |
| Function | Treatment for Cat FIP |
The product is packaged in sterile vials and labeled with batch number and expiration date.
Clinical Background of FIP
Feline Infectious Peritonitis is a viral disease that develops from mutations of feline coronavirus within the host. Although many cats carry feline coronavirus without severe symptoms, certain mutations can lead to systemic infection.
The disease is commonly classified into several forms depending on its clinical presentation:
- Wet (Effusive) FIP - accumulation of fluid in the abdomen or chest
- Dry (Non-effusive) FIP - inflammation affecting internal organs
- Ocular FIP - eye involvement such as inflammation or vision changes
- Neurological FIP - infection affecting the nervous system
Because these forms may progress differently, treatment programs often adjust dosage based on the severity and type of the condition.
Reference Dosage Protocol
| Condition | Reference Dosage |
| Wet FIP | 0.3 ml/kg body weight + 0.1 ml residue |
| Dry FIP | 0.4 ml/kg body weight + 0.1 ml residue |
| Eye / Nerve Involvement | 0.5 ml/kg body weight + 0.1 ml residue |
| Recurrence | 0.6 ml/kg body weight + 0.1 ml residue |
Body weight monitoring during treatment helps maintain consistent dosing throughout the treatment cycle.
Product Characteristics
The 20mg/ml 8ml GS-441524 injection is designed to support veterinary dosing flexibility and treatment planning. Main characteristics include:
- Standard 20mg/ml concentration suitable for common FIP protocols
- 8ml vial capacity allowing multi-day treatment cycles
- Injectable formulation enabling systemic delivery
- Clearly labeled packaging for identification and record tracking
- Room temperature storage for convenient logistics
These features make the product practical for veterinary clinics, animal hospitals, and feline care organizations.
Storage and Handling
To ensure product stability and quality:
- Store at room temperature in a dry environment
- Protect from direct sunlight or excessive heat
- Keep the vial sealed until administration
- Follow sterile handling procedures during injection
When stored according to these guidelines, the product maintains stability for up to 12 months from the manufacturing date.
Packaging and Distribution
Each GS-441524 injection vial is packaged to support safe transportation and storage. The 8ml vial format is often selected by veterinary professionals because it offers a practical balance between dosage flexibility and packaging size.
The product is typically supplied to:
- Veterinary clinics
- Animal hospitals
- Veterinary pharmaceutical distributors
- Cat rescue and rehabilitation organizations
Secure export packaging can be arranged for international shipments.
Important Notice:
This product is intended for veterinary use.
Treatment protocols and dosage decisions should be determined by qualified veterinary professionals according to the cat's medical condition.
Your message must be between 20-3,000 characters!
